Article info
PDFOriginal research
Bupropion in the treatment of postural orthostatic tachycardia syndrome (POTS): a single-center experience
- Correspondence to Dr Zeid Nesheiwat, The University of Toledo Medical Center, Toledo, OH 43606, USA; nesheiwatzeid{at}gmail.com
Citation
Bupropion in the treatment of postural orthostatic tachycardia syndrome (POTS): a single-center experience
Publication history
- Accepted June 5, 2020
- First published June 30, 2020.
Online issue publication
July 29, 2020
Article Versions
- Previous version (30 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© American Federation for Medical Research 2020. No commercial re-use. See rights and permissions. Published by BMJ.